Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Status:
Completed
Trial end date:
2017-07-15
Target enrollment:
Participant gender:
Summary
RATIONALE: Sulfasalazine may relieve diarrhea in patients with cancer who are undergoing
pelvic radiation therapy.
PURPOSE: This randomized phase III trial is studying sulfasalazine to see how well it works
in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation
therapy.